Methods of hydrolyzing a cellulose using halophilic, thermostable and ionic liquids tolerant cellulases

US9862982B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9862982-B2
Application numberUS-201615164813-A
CountryUS
Kind codeB2
Filing dateMay 25, 2016
Priority dateJun 10, 2011
Publication dateJan 9, 2018
Grant dateJan 9, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides for an isolated or recombinant polypeptide comprising an amino acid sequence having at least 70% identity with the amino acid sequence of a Halorhabdus utahensis cellulase, such as Hu-CBH1, wherein said amino acid sequence has a halophilic thermostable and/or thermophilic cellobiohydrolase (CBH) activity. In some embodiments, the polypeptide has a CBH activity that is resistant to up to about 20% of ionic liquids. The present invention also provides for compositions comprising and methods using the isolated or recombinant polypeptide.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of hydrolyzing a cellulose, comprising: (a) providing a composition comprising (i) an isolated or recombinant polypeptide comprising an amino acid sequence having at least 90% identity with the amino acid sequence of SEQ ID NO:1 or SEQ ID NO:5, wherein said isolated or recombinant polypeptide comprises a catalytic domain, a fibronectin domain 3 (FN-3) and an Ig-like domain, and has a halophilic thermostable or thermophilic cellobiohydrolase (CBH) activity, (ii) a suitable salt concentration, (iii) an ionic liquid (IL), and (iv) a cellulose; and (b) incubating the composition for a suitable length of time, such that the cellulose is hydrolyzed by the polypeptide. 2. The method of claim 1 , wherein the composition comprises a pretreatment biomass. 3. The method of claim 1 , wherein the amino acid sequence has at least 95% identity with the amino acid sequence of SEQ ID NO:1 or SEQ ID NO:5. 4. The method of claim 3 , wherein the amino acid sequence has at least 99% identity with the amino acid sequence of SEQ ID NO:1 or SEQ ID NO:5. 5. The polypeptide of claim 4 , wherein the amino acid sequence of the polypeptide comprises the amino acid sequence of SEQ ID NO:1 or SEQ ID NO:5. 6. The method of claim 2 , wherein the composition has a temperature of from about 37° C. to about 90° C. 7. The method of claim 6 , wherein the composition has a temperature of from about 50° C. to about 90° C. 8. The method of claim 7 , wherein the composition has a temperature of from about 60° C. to about 90° C. 9. The method of claim 2 , wherein the composition has a NaCl, or other suitable salt, or mixture thereof, concentration of from about 0.1 M to about 5 M. 10. The method of claim 9 , wherein the composition has a NaCl, or other suitable salt, or mixture thereof, concentration of from about 2 M to about 5 M. 11. The method of claim 2 , wherein the composition has a pH of from 7.5 to 12.5. 12. The method of claim 11 , wherein the composition has a pH of equal to or more than about 8 pH. 13. The method of claim 2 , wherein the composition has a concentration of IL equal to or more than 1% w/w. 14. The method of claim 13 , wherein the composition has a concentration of IL of 20 to 30%. 15. The method of claim 2 , wherein the composition comprises 1-alkyl-3-alkylimidazolium alkanate, 1-alkyl-3-alkylimidazolium alkylsulfate, 1-alkyl-3-alkylimidazolium methylsulfonate, 1-alkyl-3-alkylimidazolium hydrogensulfate, 1-alkyl-3-alkylimidazolium thiocyanate, or 1-alkyl-3-alkylimidazolium halide, wherein an “alkyl” is an alkyl group comprising from 1 to 10 carbon atoms, and an “alkanate” is an alkanate comprising from 1 to 10 carbon atoms. 16. The method of claim 15 , wherein the composition comprises 1-allyl-3-methylimidazolium acetate (AMIM Acetate), 1-allyl-3-methylimidazolium chloride (AMIM Cl), 1-allyl-3-methylimidazolium hydrogensulfate (AMIM HOSO 3 ), 1-allyl-3-methylimidazolium methylsulfate (AMIM MeOSO 3 ), 1-allyl-3-methylimidazolium ethylsulfate (AMIM EtOSO 3 ), 1-allyl-3-methylimidazolium methanesulfonate (AMIM MeSO 3 ), 1-allyl-3-methylimidazolium tetrachloroaluminate (AMIM AlCl 4 ), 1-ethyl-3-methylimidazolium acetate (EMIM Acetate), 1-ethyl-3-methylimidazolium chloride (EMIM Cl), 1-ethyl-3-methylimidazolium hydrogensulfate (EMIM HOSO 3 ), 1-ethyl-3-methylimidazolium methylsulfate (EMIM MeOSO 3 ), 1-ethyl-3-methylimidazolium ethylsulfate (EMIM EtOSO 3 ), 1-ethyl-3-methylimidazolium methanesulfonate (EMIM MeSO 3 ), 1-ethyl-3-methylimidazolium tetrachloroaluminate (EMIM AlCl 4 ), 1-ethyl-3-methylimidazolium thiocyanate (EMIM SCN), 1-butyl-3-methylimidazolium acetate (BMIM Acetate), 1-butyl-3-methylimidazolium chloride (BMIM Cl), 1-butyl-3-methylimidazolium hydrogensulfate (BMIM HOSO 3 ), 1-butyl-3-methylimidazolium methanesulfonate (BMIM MeSO 3 ), 1-butyl-3-methylimidazolium methylsulfate (BMIM MeOSO 3 ), 1-butyl-3-methylimidazolium tetrachloroaluminate (BMIM AlCl 4 ), 1-butyl-3-methylimidazolium thiocyanate (BMIM SCN), 1-ethyl-2,3-dimethylimidazolium ethylsulfate (EDIM EtOSO 3 ), Tris(2-hydroxyethyl)methylammonium methylsulfate (MTEOA MeOSO 3 ), 1-methylimidazolium chloride (MIM Cl), 1-methylimidazolium hydrogensulfate (MIM HOSO 3 ), 1,2,4-trimethylpyrazolium methylsulfate, tributylmethylammonium methylsulfate, choline acetate, choline salicylate, or a mixture thereof. 17. The method of claim 2 , wherein the incubating step results in at least 50% hydrolysis of the cellulose into cellobioses. 18. The method of claim 17 , wherein the incubating step results in at least 70% hydrolysis of the cellulose into cellobioses.

Assignees

Inventors

Classifications

  • Cellulose 1,4-beta-cellobiosidase (3.2.1.91) · CPC title

  • Pretreatment of cellulosic or lignocellulosic material for subsequent enzymatic treatment or hydrolysis · CPC title

  • using catalysts, e.g. selective catalysts · CPC title

  • Monosaccharides (2-ketogulonic acid C12P7/60) · CPC title

  • Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9862982B2 cover?
The present invention provides for an isolated or recombinant polypeptide comprising an amino acid sequence having at least 70% identity with the amino acid sequence of a Halorhabdus utahensis cellulase, such as Hu-CBH1, wherein said amino acid sequence has a halophilic thermostable and/or thermophilic cellobiohydrolase (CBH) activity. In some embodiments, the polypeptide has a CBH activity t…
Who is the assignee on this patent?
Univ California, Sandia Corp
What technology area does this patent fall under?
Primary CPC classification C12P19/14. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).